Abstract: An information processing device according to the present application includes a generation unit and a providing unit. The generation unit uses a model that is trained to learn a relationship between a criterion for classifying users of a first company and a criterion for classifying users of a second company to generate a criterion (common key) for classifying the users of the second company into a first category, from the criterion for classifying the users of the first company into the first category. The providing unit provides a criterion generated by the generation unit.

Abstract: A system for decentralized federated learning is provided. The system comprises agents and aggregators coupled to a communication network. Each agent comprises a data collector collecting raw data; a memory storing the collected raw data and a local machine learning model; and a processor training the local machine learning model. Each aggregator comprises a model collector collecting the local machine learning models; a memory storing the collected local machine learning models; and a processor creating a cluster machine learning model from the local machine learning models. The aggregators communicate with each other and exchange the cluster machine learning models to create a semi-global machine learning model. Each of the aggregators sends the semi-global machine learning model to the associated agents. Each of the agents updates the local machine learning model with the semi-global machine learning model.

Abstract: The present invention relates to a compound having RET kinase inhibiting action or a pharmaceutically acceptable salt thereof, useful in the treatment of diseases such as cancer. In particular a compound represented by the following general formula (I) as defined herein: or a pharmaceutically acceptable salt thereof.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of BTK, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: A forged crankshaft manufacturing apparatus processes a forged blank with no flash. The forged blank includes at least one rough crank arm having an excess portion protruding from an outer periphery of a side portion thereof. The manufacturing apparatus includes a first die and a second die paired with each other, a retaining device, and a moving device. The first die and the second die bend or crash the excess portion. The retaining device retains at least one of the rough journals or at least one of the rough pins such that a rough pin decentering direction is perpendicular to a reducing direction in which the first die and the second die apply force for reduction. The moving device supports the retaining device such that the retaining device is movable in the reducing direction.

Abstract: The present invention relates to a compound having RET kinase inhibiting action or a pharmaceutically acceptable salt thereof, useful in the treatment of diseases such as cancer. In particular a compound represented by the following general formula (I) as defined herein: (I) or a pharmaceutically acceptable salt thereof.

Abstract: Systems and methods for controlling battery charge levels to maximize savings in a behind the meter energy management system include predicting a demand charge threshold with a power demand management controller based on historical load. A net energy demand is predicted for a current day with a short-term forecaster. A demand threshold maximizes financial savings using the net energy demand using a rolling time horizon optimizer by concurrently optimizing the demand charge savings and demand response rewards. A load reduction capability factor of batteries is determined with a real-time controller corresponding to an amount of energy to fulfill the demand response rewards. The net energy demand is compared with the demand threshold to determine a demand difference. Battery charge levels of the one or more batteries are controlled with the real time controller according to the demand difference and the load reduction capability factor.

Abstract: Systems and methods for controlling battery charge levels to maximize savings in a behind the meter energy management system include predicting a demand charge threshold with a power demand management controller based on historical load. A net energy demand is predicted for a current day with a short-term forecaster. A demand threshold maximizes financial savings using the net energy demand using a rolling time horizon optimizer by concurrently optimizing the demand charge savings and demand response rewards. A load reduction capability factor of batteries is determined with a real-time controller corresponding to an amount of energy to fulfill the demand response rewards. The net energy demand is compared with the demand threshold to determine a demand difference. Battery charge levels of the one or more batteries are controlled with the real time controller according to the demand difference and the load reduction capability factor.

Abstract: A computer-implemented method, system, and computer program product are provided for anomaly detection in a power system. The method includes receiving, by a processor-device, a plurality of measurements from a plurality of meters throughout the power system. The method also includes generating, by the processor-device, temporal causal networks based on pair-wise relationships between the plurality of measurements from the plurality of meters over time. The method additionally includes determining, by the processor-device, invariant relationships for the plurality of meters between the temporal causal networks. The method further includes predicting, by the processor-device, an anomaly from the invariant relationships for the plurality of meters with a residual anomaly threshold. The method also includes disabling one of the plurality of meters that originated the anomaly.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: The present invention relates to a compound having RET kinase inhibiting action or a pharmaceutically acceptable salt thereof, useful in the treatment of diseases such as cancer. In particular a compound represented by the following general formula (I) as defined herein: (I) or a pharmaceutically acceptable salt thereof.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of BTK, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: A system and methods are provided for a decentralized transactive energy management. The method includes calculating, by a processor-device, power balancing at one of a plurality of nodes responsive to current statistics at the one of a plurality of nodes. The method also includes estimating, by the processor-device, a present energy demand for the one of a plurality of nodes responsive to the current statistics. The method additionally includes obtaining, by the processor-device, an amount of excess energy available another of the plurality of nodes. The method further includes optimizing, by the processor-device, a power flow between the one of the plurality of nodes and the another of the plurality of nodes to satisfy the present energy demand for the one of the plurality of nodes. The method also includes transferring the excess energy from the another of the plurality of nodes to the one of the plurality of nodes.

Abstract: The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt thereof, tautomer, prodrug, solvate, metabolite, polymorph, analog or derivative thereof, which modulates the activity of BTK, a pharmaceutical composition comprising the compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

Abstract: Systems and methods for controlling battery charge levels to maximize savings in a behind the meter energy management system include predicting a demand charge threshold with a power demand management controller based on historical load. A net energy demand is predicted for a current day with a short-term forecaster. A demand threshold maximizes financial savings using the net energy demand using a rolling time horizon optimizer by concurrently optimizing the demand charge savings and demand response rewards. A load reduction capability factor of batteries is determined with a real-time controller corresponding to an amount of energy to fulfill the demand response rewards. The net energy demand is compared with the demand threshold to determine a demand difference. Battery charge levels of the one or more batteries are controlled with the real time controller according to the demand difference and the load reduction capability factor.

Abstract: Systems and methods for controlling battery charge levels to maximize savings in a behind the meter energy management system include predicting a demand charge threshold with a power demand management controller based on historical load. A net energy demand is predicted for a current day with a short-term forecaster. A demand threshold maximizes financial savings using the net energy demand using a rolling time horizon optimizer by concurrently optimizing the demand charge savings and demand response rewards. A load reduction capability factor of batteries is determined with a real-time controller corresponding to an amount of energy to fulfill the demand response rewards. The net energy demand is compared with the demand threshold to determine a demand difference. Battery charge levels of the one or more batteries are controlled with the real time controller according to the demand difference and the load reduction capability factor.

Abstract: A computer-implemented method, system, and computer program product are provided for anomaly detection in a power system. The method includes receiving, by a processor-device, a plurality of measurements from a plurality of meters throughout the power system. The method also includes generating, by the processor-device, temporal causal networks based on pair-wise relationships between the plurality of measurements from the plurality of meters over time. The method additionally includes determining, by the processor-device, invariant relationships for the plurality of meters between the temporal causal networks. The method further includes predicting, by the processor-device, an anomaly from the invariant relationships for the plurality of meters with a residual anomaly threshold. The method also includes disabling one of the plurality of meters that originated the anomaly.